CAS: 203115-63-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SID 487795 REF: IN-DA00BJQVCAS: 203115-63-3 | 97% | To inquire | Thu 13 Feb 25 |
 | NSC 617145 REF: TM-T9168CAS: 203115-63-3 | 98.31% - 99.72% | 37.00 €~875.00 € | Thu 20 Feb 25 |
 | NSC 617145 REF: TR-N900535CAS: 203115-63-3 | - - - | 1,151.00 € | Wed 26 Mar 25 |
 | NSC 617145 REF: 3D-DIA11563CAS: 203115-63-3 | Min. 95% | 341.00 €~1,630.00 € | Thu 27 Mar 25 |
SID 487795
CAS:203115-63-3
Formula:
C13H10Cl4N2O4
Purity:
97%
Color and Shape:
Solid
Molecular weight:
400.0415
Ref: IN-DA00BJQV
| 10mg | 146.00 € | ||
| 50mg | 552.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 13 Feb 2025
NSC 617145
CAS:203115-63-3
NSC 617145 (NSC617145) is an inhibitor of WRN helicase that inhibits the ATPase, but not …
Formula:
C13H10Cl4N2O4
Purity:
98.31% - 99.72%
Color and Shape:
Solid
Molecular weight:
400.04
- Inhibitors
- Cell Cycle/Checkpoint
- ATPase
- Microbiology/Virology
- See more categories
- DNA/RNA Synthesis
Ref: TM-T9168
| 1mg | 37.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 75.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 237.00 € | ||
| 100mg | 369.00 € | ||
| 500mg | 875.00 € | ||
| 1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Thursday 20 Feb 2025
NSC 617145
Controlled ProductCAS:203115-63-3
Applications NSC 617145 is ahelicase inhibitor used in the treatment of Werner syndrome helicase and …
Formula:
C13H10Cl4N2O4
Color and Shape:
Neat
Molecular weight:
400.04
Ref: TR-N900535
| 100mg | 1,151.00 € |
Estimated delivery in United States, on Wednesday 26 Mar 2025
NSC 617145
CAS:203115-63-3
NSC 617145 is a molecule that inhibits leukemia inhibitory factor (LIF) activity by binding to …
Formula:
C13H10Cl4N2O4
Purity:
Min. 95%
Molecular weight:
400.04 g/mol
Ref: 3D-DIA11563
| 5mg | 341.00 € | ||
| 10mg | 426.00 € | ||
| 25mg | 710.00 € | ||
| 50mg | 1,019.00 € | ||
| 100mg | 1,630.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
